PMC · DOI:10.1007/s10238-024-01393-1·July 18, 2024
Correction to: SRRM2 may be a potential biomarker and immunotherapy target for multiple myeloma: a real-world study based on flow cytometry detection
Jinjing Guo, Zhiye Zhang, Huiping Wang, Qian Li, Mengmeng Fan, Wanqiu Zhang, Qianshan Tao, Zhitao Wang, Chun Ling, Hao Xiao, Zhimai Gao, Zhimin Zhai
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMultiple Myeloma Research and Treatments · Lung Cancer Research Studies · Cancer therapeutics and mechanisms